Ω-3 fatty acid supplements for cancer-associated weight loss

Aminah Jatoi

doi:10.1177/0115426505020004394

Ω-3 fatty acid supplements for cancer-associated weight loss

Aminah Jatoi

Medical Oncology

Research output: Contribution to journal › Review article › peer-review

4 Scopus citations

Abstract

Ω-3 fatty acids have been tested for the treatment of cancer anorexia/weight loss, a syndrome that predicts a poor prognosis among cancer patients with incurable disease: This review focuses on both the preclinical and clinical data of ω-3 fatty acids for treating this syndrome. Overall, the promise of the former does not seem to be borne out completely in the latter. This review includes a discussion of how these data might be interpreted and explained to cancer patients who are striving to cope with this syndrome.

Original language	English (US)
Pages (from-to)	394-399
Number of pages	6
Journal	Nutrition in Clinical Practice
Volume	20
Issue number	4
DOIs	https://doi.org/10.1177/0115426505020004394
State	Published - 2005

ASJC Scopus subject areas

Medicine (miscellaneous)
Nutrition and Dietetics

Access to Document

10.1177/0115426505020004394

Cite this

@article{13916f2722af4f3ca24906215b775661,

title = "Ω-3 fatty acid supplements for cancer-associated weight loss",

abstract = "Ω-3 fatty acids have been tested for the treatment of cancer anorexia/weight loss, a syndrome that predicts a poor prognosis among cancer patients with incurable disease: This review focuses on both the preclinical and clinical data of ω-3 fatty acids for treating this syndrome. Overall, the promise of the former does not seem to be borne out completely in the latter. This review includes a discussion of how these data might be interpreted and explained to cancer patients who are striving to cope with this syndrome.",

author = "Aminah Jatoi",

year = "2005",

doi = "10.1177/0115426505020004394",

language = "English (US)",

volume = "20",

pages = "394--399",

journal = "Nutrition in Clinical Practice",

issn = "0884-5336",

publisher = "SAGE Publications Ltd",

number = "4",

}

TY - JOUR

T1 - Ω-3 fatty acid supplements for cancer-associated weight loss

AU - Jatoi, Aminah

PY - 2005

Y1 - 2005

N2 - Ω-3 fatty acids have been tested for the treatment of cancer anorexia/weight loss, a syndrome that predicts a poor prognosis among cancer patients with incurable disease: This review focuses on both the preclinical and clinical data of ω-3 fatty acids for treating this syndrome. Overall, the promise of the former does not seem to be borne out completely in the latter. This review includes a discussion of how these data might be interpreted and explained to cancer patients who are striving to cope with this syndrome.

AB - Ω-3 fatty acids have been tested for the treatment of cancer anorexia/weight loss, a syndrome that predicts a poor prognosis among cancer patients with incurable disease: This review focuses on both the preclinical and clinical data of ω-3 fatty acids for treating this syndrome. Overall, the promise of the former does not seem to be borne out completely in the latter. This review includes a discussion of how these data might be interpreted and explained to cancer patients who are striving to cope with this syndrome.

UR - http://www.scopus.com/inward/record.url?scp=33644825864&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33644825864&partnerID=8YFLogxK

U2 - 10.1177/0115426505020004394

DO - 10.1177/0115426505020004394

M3 - Review article

C2 - 16207679

AN - SCOPUS:33644825864

SN - 0884-5336

VL - 20

SP - 394

EP - 399

JO - Nutrition in Clinical Practice

JF - Nutrition in Clinical Practice

IS - 4

ER -

Ω-3 fatty acid supplements for cancer-associated weight loss

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this